Literature DB >> 4825979

Interactions of standard antibody with Australia antigens in Au Ag-Ab radioimmunoassay.

H Daugharty, R G Young, M H Hatch, D W Ziegler.   

Abstract

Human antisera against Australia (Au) antigen have been characterized by liquid-phase radioimmunoassay (RIA) for their precipitation of (125)I-labeled Au antigen. The end-point dilutions of sera (anti-Au) which precipitated 50% of (125)I-Au antigen by RIA correlated well with complement fixation titers but had a much wider range, indicating a greater precision and perhaps a better sensitivity of assay. Anti-Au serum diluted to precipitate 50% of (125)I-labeled Au antigen was used as standard antibody in RIA tests to detect either inhibition or enhancement of the reaction by preincubated mixtures of Au antigen and antibody specimens. Without free Au antigen or antibody in the resultant mixtures there was no inhibition or enhancement; the mixtures presumably contained immunoreactively equivalent proportions of Au antigen and antibody. RIA data for diagnostic specimens indicated an end-point sensitivity which was proportional to the dilution of the standard anti-Au sera used in the test. High concentrations of the standard antibody permitted detectable inhibition of (125)I-Au antigen precipitation at lower antigen specimen concentrations. Similarly, low concentrations of the standard antibody permitted detectable enhancement of (125)I-Au antigen precipitation at lower antibody specimen concentrations. Omitting the standard antibody altogether resulted in a more sensitive RIA for Au antibody in test sera.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4825979      PMCID: PMC380130          DOI: 10.1128/am.27.4.756-762.1974

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  19 in total

1.  Immunoprecipitin reaction of influenza virus-antibody complex with anti-IgG.

Authors:  H Daugharty
Journal:  J Immunol       Date:  1971-09       Impact factor: 5.422

2.  Assay of Australia antigen and antibody employing double-antibody and solid-phase radioimmunoassay techniques and comparison with the passive hemagglutination methods.

Authors:  F B Hollinger; V Vorndam; G R Dreesman
Journal:  J Immunol       Date:  1971-10       Impact factor: 5.422

3.  Studies on the immunogenicity of antigen-antibody precipitates. 1. The suppressive effect of anti-L and anti-H chain antibodies on the immunogenicity of human gammaG globulin.

Authors:  C S Henney; K Ishizaka
Journal:  J Immunol       Date:  1968-11       Impact factor: 5.422

4.  Frequency of antibody to hepatitis-associated antigen as measured by a new radioimmunoassay technique.

Authors:  J J Lander; H J Alter; R H Purcell
Journal:  J Immunol       Date:  1971-05       Impact factor: 5.422

5.  Australia antigen: large-scale purification from human serum and biochemical studies of its proteins.

Authors:  J L Gerin; P V Holland; R H Purcell
Journal:  J Virol       Date:  1971-05       Impact factor: 5.103

6.  Preparation and characterization of complement-fixing hepatitis-associated antigen and antiserum.

Authors:  R H Purcell; J L Gerin; P V Holland; W L Cline; R M Chanock
Journal:  J Infect Dis       Date:  1970-02       Impact factor: 5.226

7.  Hemagglutination assay for antigen and antibody associated with viral hepatitis.

Authors:  G N Vyas; N R Shulman
Journal:  Science       Date:  1970-10-16       Impact factor: 47.728

8.  Detection of Australia antigen by radioimmunoassay.

Authors:  R D Aach; J W Grisham; C W Parker
Journal:  Proc Natl Acad Sci U S A       Date:  1971-05       Impact factor: 11.205

9.  Antibody against serum-hepatitis antigen. Prevalence and potential use as immune serum globulin in prevention of serum-hepatitis infections.

Authors:  A M Prince; W Szmuness; K R Woods; G F Grady
Journal:  N Engl J Med       Date:  1971-10-21       Impact factor: 91.245

10.  Australia antigen (a hepatitis-associated antigen): purification and physical properties.

Authors:  I Millman; L A Loeb; M E Bayer; B S Blumberg
Journal:  J Exp Med       Date:  1970-06-01       Impact factor: 14.307

View more
  1 in total

1.  Platelet aggregation by hepatitis B surface antigen-antibody complexes.

Authors:  H Daugharty; R Gogel
Journal:  Infect Immun       Date:  1976-09       Impact factor: 3.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.